Jack A Elias Selected Research

Chitinase-3-Like Protein 1

3/2022	Potential role of chitinase-3-like protein 1 (CHI3L1/YKL-40) in neurodegeneration and Alzheimer's disease.
1/2022	Proteome-Wide Analysis Using SOMAscan Identifies and Validates Chitinase-3-Like Protein 1 as a Risk and Disease Marker of Delirium Among Older Adults Undergoing Major Elective Surgery.
1/2014	Increased plasma YKL-40/chitinase-3-like-protein-1 is associated with endothelial dysfunction in obstructive sleep apnea.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jack A Elias Research Topics

Disease

72	Inflammation (Inflammations) 01/2022 - 03/2002
37	Fibrosis (Cirrhosis) 01/2022 - 03/2002
36	Asthma (Bronchial Asthma) 01/2022 - 07/2002
20	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022 - 10/2002
17	Pneumonia (Pneumonitis) 01/2019 - 03/2002
11	Infections 02/2022 - 06/2004
11	Metaplasia 06/2012 - 03/2002
11	Hyperoxia 05/2012 - 08/2003
10	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 08/2006
10	Emphysema 06/2012 - 06/2005
9	Neoplasm Metastasis (Metastasis) 01/2022 - 05/2012
9	Respiratory Hypersensitivity 08/2010 - 07/2002
8	Neoplasms (Cancer) 01/2022 - 12/2008
8	Lung Injury 01/2016 - 04/2005
8	Acute Lung Injury 05/2012 - 10/2003
7	COVID-19 02/2022 - 09/2020
7	Lung Diseases (Lung Disease) 01/2022 - 07/2002
7	Airway Remodeling 03/2016 - 09/2002
6	Hyperplasia 01/2022 - 08/2003
6	Pulmonary Emphysema 01/2021 - 05/2005
5	Idiopathic Pulmonary Fibrosis 01/2022 - 06/2011
5	Vascular Remodeling 04/2013 - 10/2004
5	Edema (Dropsy) 11/2011 - 10/2004
4	Melanoma (Melanoma, Malignant) 01/2016 - 05/2012
4	Bronchopulmonary Dysplasia 05/2012 - 12/2004
4	Respiratory Insufficiency (Respiratory Failure) 02/2005 - 03/2002
3	Virus Diseases (Viral Diseases) 12/2015 - 08/2008
3	Eosinophilia 12/2005 - 08/2002
2	Macrophage Activation Syndrome 01/2021 - 11/2020
2	Insulin Resistance 01/2021 - 11/2009
2	Chronic Disease (Chronic Diseases) 11/2020 - 10/2019
2	Respiratory Syncytial Virus Infections 01/2019 - 11/2006
2	Hermanski-Pudlak Syndrome (Hermansky-Pudlak Syndrome) 01/2018 - 08/2015
2	Delayed Graft Function 01/2017 - 02/2013
2	Colitis 11/2015 - 05/2014

Drug/Important Bio-Agent (IBA)

47	ChitinasesIBA 02/2022 - 06/2004
35	Interleukin-13IBA 01/2022 - 03/2002
33	Proteins (Proteins, Gene)FDA Link 02/2022 - 02/2004
28	CytokinesIBA 01/2021 - 08/2002
17	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2017 - 10/2004
14	Biomarkers (Surrogate Marker)IBA 03/2022 - 04/2008
13	AllergensIBA 11/2020 - 08/2002
10	Transforming Growth Factors (Transforming Growth Factor)IBA 01/2022 - 04/2003
9	SmokeIBA 12/2015 - 12/2005
8	Peptide Hydrolases (Proteases)FDA Link 02/2022 - 01/2004
8	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 10/2002
8	ChitinIBA 01/2018 - 06/2004
8	Oxidants (Oxidizing Agents)IBA 01/2016 - 04/2005
8	ChemokinesIBA 02/2009 - 03/2002
7	InterleukinsIBA 01/2022 - 07/2002
6	Messenger RNA (mRNA)IBA 10/2019 - 09/2002
6	Interleukin-11 (Interleukin 11)IBA 12/2008 - 03/2003
5	Interleukin-6 (Interleukin 6)IBA 01/2022 - 10/2003
5	Oxygen (Dioxygen)IBA 01/2021 - 10/2003
5	Transforming Growth Factor beta1 (TGF beta 1)IBA 01/2015 - 12/2004
5	Interleukin-4 (Interleukin 4)IBA 01/2013 - 08/2002
4	CollagenIBA 01/2022 - 03/2006
4	LigandsIBA 11/2021 - 02/2009
4	chitotriosidaseIBA 01/2021 - 05/2014
4	Small Interfering RNA (siRNA)IBA 01/2018 - 11/2006
4	Interleukin-17 (Interleukin 17)IBA 01/2013 - 04/2003
4	Transforming Growth Factor beta (TGF-beta)IBA 01/2011 - 01/2004
3	Chitinase-3-Like Protein 1IBA 03/2022 - 01/2014
3	kasugamycinIBA 02/2022 - 01/2022
3	indium-bleomycinIBA 01/2022 - 03/2007
3	LipidsIBA 01/2021 - 05/2005
3	OvalbuminIBA 11/2020 - 08/2010
3	Immunoglobulin E (IgE)IBA 11/2020 - 12/2008
3	Antiviral Agents (Antivirals)IBA 09/2020 - 05/2011
3	Mitogen-Activated Protein KinasesIBA 01/2020 - 01/2006
3	Matrix Metalloproteinases (MMPs)IBA 01/2017 - 08/2002
3	AmphiregulinIBA 03/2016 - 12/2012
3	Interleukin-13 Receptors (Interleukin 13 Receptor)IBA 03/2016 - 01/2013
3	Interleukin-18 (Interleukin 18)IBA 12/2015 - 02/2007
3	EnzymesIBA 03/2015 - 08/2002
3	AntigensIBA 03/2015 - 10/2004
3	Semaphorins (Semaphorin)IBA 02/2015 - 05/2007
3	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 08/2013 - 05/2007
3	Interleukin-10 (Interleukin 10)IBA 01/2013 - 09/2002
3	Angiopoietin-2IBA 05/2012 - 05/2007
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 04/2012 - 04/2006
3	Poly I-CIBA 11/2011 - 08/2008
3	CaspasesIBA 05/2011 - 06/2005
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2011 - 10/2002
3	Biological ProductsIBA 09/2010 - 04/2007
3	Adenosine (Adenocard)FDA LinkGeneric 05/2006 - 08/2003
3	Protease Inhibitors (Protease Inhibitor)IBA 01/2006 - 02/2004
2	Pharmaceutical PreparationsIBA 01/2022 - 09/2020
2	RNA (Ribonucleic Acid)IBA 01/2022 - 03/2016
2	C-Reactive ProteinIBA 01/2022 - 06/2014
2	HydrolasesIBA 01/2022 - 01/2022
2	Insulin (Novolin)FDA Link 01/2021 - 11/2009
2	Amyloid (Amyloid Fibrils)IBA 12/2020 - 01/2011
2	CateninsIBA 01/2020 - 08/2013
2	Peptides (Polypeptides)IBA 01/2018 - 03/2015
2	plexinIBA 12/2016 - 02/2015
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016 - 03/2008
2	InflammasomesIBA 06/2015 - 08/2013

Therapy/Procedure

8	Therapeutics 01/2022 - 10/2003
2	Transplantation 01/2022 - 02/2013